UK adopts all 44 health AI regulation proposals; Teladoc adds AI scribe for hospitals; AHRQ offers $7.95 million AI prize; Anthropic opens cyber models to hospitals
Listen to this post
read by AI voices ยท all episodesTHE SHORT READ
The British government on Oct. 6 accepted all 44 recommendations of a national commission on regulating artificial intelligence in health care, committing to closer monitoring of AI devices after they reach clinical use.
The response commits health departments to review how responsibility is divided between manufacturers and the providers who use AI, and it says patients have a "reasonable expectation of being informed" about AI in their care. A fuller implementation plan is due by spring 2027, according to the government response.
In the United States, Teladoc Health released an ambient documentation tool and previewed camera-based vital signs for the hospital telehealth platform it says runs in more than 15,000 care locations. The Agency for Healthcare Research and Quality opened a prize competition of up to $7.95 million for AI that speeds evidence reviews, and Anthropic said regional hospitals can now apply for access to its most capable cybersecurity models. The day also brought an Ochsner Health report on AI screening for cancer trials and studies in neurology and kidney pathology.
THE DETAILS
- Regulation Oct 6, 2026The Medicines and Healthcare products Regulatory Agency, Britain's device regulator, will build a framework with "less reliance on point-in-time pre-market assessments," a public database of adverse incidents and a new phase of its AI Airlock testing program focused on devices already in clinical use, according to the government response published Oct. 6. Health departments will review how to allocate responsibility between manufacturers and providers, NHS England and NHS Resolution will issue indemnity guidance, and providers must ensure staff are trained to use the tools, the document says. Manufacturers would be expected to report their dependence on general-purpose AI models. The National Commission into the Regulation of AI in Healthcare published its report Sept. 10, and further details are due by spring 2027, The Pharmaceutical Journal reported. Lawrence Tallon, head of the agency, said many countries are asking about the British approach, according to Reuters.
- Deployment Oct 7, 2026SoloScribe, an ambient documentation tool that drafts structured notes from in-person and virtual visits and sends them to the electronic health record, is available now, Teladoc Health said Oct. 7. SoloVitals measures heart and respiratory rates without contact by reading changes in facial skin color through a device camera; it is in private preview, with broad release expected in December. The Solo platform runs in more than 15,000 care locations worldwide, according to Joby McKenzie, general manager of the company's North American health systems business. The reports do not state SoloVitals' regulatory status or any accuracy data. Teladoc reported a net loss of $200.3 million in 2025, Healthcare Dive reported.Sources: Fierce Healthcare, Healthcare Dive
- Money Oct 7, 2026The Agency for Healthcare Research and Quality's Clinical Evidence Synthesis Transformation Challenge carries a $5.35 million grand prize, and a second contest asks teams to build applications on the agency's cost, utilization and quality databases, the agency said Oct. 7. Entries will be judged on accuracy, throughput, reproducibility, usability and ease of operation. Phase 1 submissions are due March 12, 2027, and tech sprint entries Sept. 9, 2027. The agency named the program a Super Intelligence initiative after President Donald Trump's Sept. 29 executive order on the term. "Reliable clinical evidence is critical for doctors, patients, payers and policymakers," said Dr. Roger Klein, the agency's director.Sources: AHRQ, Becker's Hospital Review
- Deployment Oct 6, 2026Anthropic folded its Project Glasswing, which had limited its Claude Mythos model to about 200 organizations, into a three-tier Cyber Verification Program open to "operators of critical infrastructure of any size, such as regional hospitals," the company said Oct. 6. The defense tier covers security operations, incident response and vulnerability analysis, with applications answered within a few days, according to the company. Enrolled organizations must allow data retention so the company can monitor misuse until a zero-retention option arrives later this fall. Glasswing partners found at least 129,000 verified vulnerabilities from April to July, more than 33,000 of them rated critical or high severity, the company said; Epic is among the members, Becker's reported.Sources: Anthropic, Becker's Hospital Review
- Deployment Oct 6, 2026Ochsner Health, which runs 47 hospitals in Louisiana and Mississippi, uses Paradigm Health's platform inside the electronic health record to screen patients against eligibility criteria for open oncology trials and to follow patients who may qualify later, Healthcare IT News reported Oct. 6. The health system reported 3.6 times as many patients followed for future eligibility; the figures are Ochsner's own. Research coordinators review candidates, and clinical teams make eligibility and enrollment decisions. "Screening is not the same as enrollment," said Dr. Joseph Biggio, the system's vice chief scientific officer.Source: Healthcare IT News
- Evidence Oct 8, 2026University of Minnesota researchers fine-tuned large language models on routine clinical notes to detect epilepsy early and tested the tool, EpiScreen, on the public MIMIC-IV database and a private university cohort, reporting areas under the curve of up to 0.875 and 0.980, according to the paper published Oct. 8 in npj Digital Medicine. Neurologists assisted by the tool outperformed unaided experts by up to 14.3%, the authors reported. The figures are maximums across models, the work is retrospective, and the article is an early-access version subject to edits. The authors described the tool as a low-cost screen for settings with limited resources.Source: npj Digital Medicine
- Evidence Oct 6, 2026Pathology AI classified membranous nephropathy, IgA nephropathy and minimal change disease with pooled accuracies of 0.94 to 0.96 across 39,536 validation samples, which were not necessarily unique patients, according to a systematic review in Renal Failure indexed Oct. 6. AI showed higher accuracy than senior pathologists for those three diseases, but head-to-head evidence was sparse, most studies were retrospective and heterogeneity was substantial, the authors said. They concluded that current evidence is insufficient to establish superiority over pathologists and called for prospective multicenter studies.Sources: Renal Failure, PubMed record
- Money Oct 7, 2026The company, founded by former PillPack and Amazon Pharmacy executives, closed a $120 million Series B led by Andreessen Horowitz, with Eli Lilly and Mercy Health's investment arm among participants, Fierce Healthcare reported Oct. 7. It sells more than 2,900 medications, lab tests, telehealth visits and select in-person services, offers an AI chat interface alongside clinician consultations, and plans to let AI agents search for and buy care on a patient's behalf, according to the report. Licensed clinicians in its own medical group make clinical determinations when review is required. The company said it has hundreds of thousands of customers in every state.Source: Fierce Healthcare
- Money Oct 7, 2026The Department of Energy pledged more than $500 million over five years, Google DeepMind, Isomorphic Labs and Meta $300 million combined, and Biohub $500 million, while the National Institutes of Health is coordinating datasets from more than $500 million in earlier federal spending, Biohub said Oct. 7. The effort aims to build open, AI-ready datasets for models that predict how cells respond, as groundwork for understanding and treating disease. The NIH contribution is not new money, according to the release.Source: Biohub (PR Newswire)